Hot Features
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, ... CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.319 | -7.46505178561 | 17.669 | 17.669 | 16.29 | 876506 | 17.14089356 | DR |
| 4 | -5.66 | -25.7155838255 | 22.01 | 22.28 | 16.29 | 600799 | 17.75014734 | DR |
| 12 | -8.56 | -34.3637093537 | 24.91 | 26.61 | 16.29 | 537406 | 21.8397678 | DR |
| 26 | -42.61 | -72.2693351425 | 58.96 | 67.0632 | 16.29 | 354880 | 29.66330582 | DR |
| 52 | -63.4 | -79.4984326019 | 79.75 | 89.71 | 16.29 | 237840 | 39.76368593 | DR |
| 156 | -86.675 | -84.1300655181 | 103.025 | 109 | 16.29 | 128741 | 57.66179809 | DR |
| 260 | -95.8817 | -85.4319234227 | 112.2317 | 117.49 | 16.29 | 99239 | 66.75358294 | DR |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.